Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HSD17B13 | Q7Z5P4 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | ANO1 | Q5XXA6 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zoxamide SCHEMBL70113 | 1.00 | LMNA (0.36) | LMNAPOLBGAAKDM4EALDH1A1 | |
| Zoxamide SCHEMBL7170744 | 1.00 | LMNA (0.36) | LMNAPOLBGAAKDM4EALDH1A1 | |
| Zoxamide SCHEMBL17701171 | 0.99 | LMNA (0.35) | LMNAPOLBGAAKDM4EALDH1A1 | |
| Zoxamide SCHEMBL17701155 | 0.95 | DDR1 (0.33) | LMNAPOLBGAAKDM4EALDH1A1 | |
| Zoxamide SCHEMBL14676134 | 0.95 | GAA (0.35) | LMNAPOLBGAAKDM4EALDH1A1 | |
| Zoxamide SCHEMBL17701169 | 0.90 | KDM4E (0.32) | LMNAPOLBGAAKDM4EALDH1A1 | |
| Zoxamide SCHEMBL21043613 | 0.89 | KDM4E (0.32) | LMNAPOLBGAAKDM4EALDH1A1 | |
| Zoxamide SCHEMBL7167110 | 0.89 | POLB (0.39) | LMNAPOLBGAAKDM4EALDH1A1 | |
| SCHEMBL7527475 | 0.87 | HSD11B1 (0.38) | LMNAGAAKDM4EALDH1A1HSD17B13 | |
| SCHEMBL7572038 | 0.87 | HSD17B13 (0.36) | LMNAPOLBGAAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9113630-B2 | Method of controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-25 | — | — | US | claimed |
| US-8921400-B2 | Arthropodicidal anthranilamides | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-12-30 | — | — | US | claimed |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | claimed |
| US-8637552-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-01-28 | — | — | US | claimed |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | claimed |
| US-20120171183-A1 | ARTHROPODICIDAL ANTHRANILAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-05 | — | — | US | claimed |
| US-20100152194-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-17 | — | — | US | claimed |
| US-7696232-B2 | Anthranilamide arthropodicide treatment | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-04-13 | — | — | US | claimed |
| EP-1700845-B1 | Insecticidal anthranilamides | DU PONT (US) | 2008-12-10 | — | — | EP | claimed |
| EP-1427285-B1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | DU PONT (US) | 2007-08-22 | — | — | EP | claimed |
| EP-1700845-A1 | Insecticidal anthranilamides | E.I.Du pont de nemours and company (US) | 2006-09-13 | — | — | EP | claimed |
| US-20040209923-A1 | Anthranilamide arthropodicide treatment | FMC CORPORATION | 2004-10-21 | — | — | US | claimed |
| EP-1427285-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. du Pont de Nemours and Company (US) | 2004-06-16 | — | — | EP | claimed |
| WO-2003024222-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-03-27 | — | — | WO | claimed |
| US-20260101901-A1 | DELAYING BLOOM IN HORTICULTURAL CROPS USING JASMONIC ACID BIOSYNTHESIS INHIBITORS | VIRGINIA TECH INTELLECTUAL PROPERTIES INC (US) | 2026-04-16 | — | — | US | disclosed |
| US-12590341-B2 | Brassica GAT event and compositions and methods for the identification and/or detection thereof | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-12221436-B2 | Anthranilamides, their use as insecticide and processes for preparing the same | PI INDUSTRIES LTD. (IN) | 2025-02-11 | — | — | US | disclosed |
| EP-0816330-B1 | Process for the preparation of N-acetonylbenzamides | ROHM & HAAS (US) | 2000-12-27 | — | — | EP | disclosed |
| WO-2000053585-A1 | AMIDE AND ESTER FUNGICIDES AND ARTHROPODICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-09-14 | — | — | WO | disclosed |
| EP-0816330-A1 | N-acetonylbenzamide fungicides | ROHM AND HAAS COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12221436-B2 | Anthranilamides, their use as insecticide and processes for preparing the same | CYP1A2, ANTXR2, DDT | LMNA 1607/4885POLB 2716/4885GAA 1835/4885 |
| US-12590341-B2 | Brassica GAT event and compositions and methods for the identification and/or detection thereof | DNTT, NAA50, NAA15 | LMNA 3503/4885POLB 53/4885GAA 1553/4885 |
| US-20260101901-A1 | DELAYING BLOOM IN HORTICULTURAL CROPS USING JASMONIC ACID BIOSYNTHESIS INHIBITORS | FADS2, DDT, MYB | LMNA 3530/4885POLB 3978/4885GAA 2706/4885 |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | LMNA 3703/4885POLB 4372/4885GAA 1554/4885 |
| US-20040209923-A1 | Anthranilamide arthropodicide treatment | ANTXR2, ARF5, NPM1 | LMNA 3468/4885POLB 4432/4885GAA 1184/4885 |
| US-20100152194-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | LMNA 3703/4885POLB 4372/4885GAA 1554/4885 |
| US-20120171183-A1 | ARTHROPODICIDAL ANTHRANILAMIDES | ANTXR2, CYB5R3, NIT2 | LMNA 3711/4885POLB 2919/4885GAA 2681/4885 |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | LMNA 3703/4885POLB 4372/4885GAA 1554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.